|Bid||6.44 x 1000|
|Ask||6.45 x 1100|
|Day's Range||6.25 - 6.49|
|52 Week Range||5.67 - 10.12|
|Beta (3Y Monthly)||0.24|
|PE Ratio (TTM)||21.98|
|Earnings Date||Feb 25, 2019 - Mar 1, 2019|
|Forward Dividend & Yield||0.08 (1.19%)|
|1y Target Est||15.00|
Global Cord Blood Corp NYSE:COView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for CO with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CO. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding CO are favorable, with net inflows of $202 million. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of December. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]
HONG KONG, April 1, 2019 /PRNewswire/ -- Global Cord Blood Corporation (CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company is increasing its processing fee by RMB3,000 to RMB9,800, effective on April 1, 2019. The Company's annual storage fee is unaffected by this increase. The Company is committed to delivering high quality and top of the line services to all clients, and this is evidenced by the Company's continuous investment in cord blood banking hardware as well as software.
3Q 19 Added 23,663 New Subscribers Revenues Up 3.7% YoY to RMB254.2 Million ( $37.0 Million ) Operating Income Increased to RMB92.6 Million ( $13.5 Million ) Conference Call to be Held on February 26, ...
Earnings Call Scheduled for 8:00 a.m. ET on February 26, 2019 HONG KONG , Feb. 19, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord ...
HONG KONG , Dec. 6, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic ...
After reading Global Cord Blood Corporation’s (NYSE:CO) latest earnings update (30 June 2018), I found it beneficial to look back at how the company has performed in the past and Read More...
2Q19 Added 22,908 New Subscribers Revenues Up 5.3% YoY to RMB247.1 Million ( $36.0 Million ) Operating Income Up 37.3% YoY to RMB104.8 Million ( $15.3 Million ) ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...
Earnings Call Scheduled for 8:00 a.m. ET on November 28 , 2018 HONG KONG , Nov. 20, 2018 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of ...